Compare prescription sensors, OTC options, and fingerstick meters by ongoing costs, glucose alerts, and device compatibility to guide your choice.

Comparing a diabetes monitor in the US means comparing more than sensor prices. Stelo lists a subscription at $89 per month, while ReliOn Premier strips start around $9.84 per box of 50 in 2026. A prescription continuous glucose monitor may cost less with coverage—but your eligibility, deductible, and plan’s preferred brand determine what you actually owe.
A continuous glucose monitor, or CGM, provides ongoing glucose readings; a traditional meter uses fingersticks and matching test strips. The first decision is whether you need prescription monitoring, an over-the-counter option, or a lower-cost meter-and-strip setup.
Type 1 diabetes, type 2 diabetes, and prediabetes do not automatically lead to the same coverage. Start with the payment path that applies to you:
The useful question: Does your plan cover the exact monitor for your documented treatment needs—not simply “diabetes supplies”?
Use these figures to set a budget, not as a quote. With insurance, a covered device can still involve a deductible, recurring copays, or coinsurance—your percentage of the allowed charge.
| Payment route or product | Indicative 2026 cost | What to check |
|---|---|---|
| Original Medicare CGM | $283 annual Part B deductible, then 20% of the Medicare-approved amount | Supplier must accept assignment; supplemental coverage may help |
| Libre with Original Medicare, without supplemental coverage | About $45–$55 monthly after the deductible | Estimate depends on approved charges and supplies |
| Commercially covered Libre | $0–$20 per sensor for most covered patients, according to the cited Abbott-based pricing guide | Deductible, authorization, and benefit routing |
| Dexcom G7 15 Day, prescription cash purchase | Around $487.89 for 2 sensors; about $185 with a GoodRx coupon | Pharmacy, coupon eligibility, and separate receiver expense |
| FreeStyle Libre 3 Plus, prescription cash purchase | Around $240 for 2 sensors; about $162 with SingleCare at Kroger | Pharmacy and discount terms |
| ReliOn Premier strips, cash purchase | Around $9.84 for 50 or $18.46 for 100 | Matching meter and lancets cost extra |
Prices, fees, and cost-sharing figures throughout this article are indicative, change over time, and vary by provider, policy, location, and eligibility; verify current amounts with the official manufacturer, retailer, or plan.
Medigap may cover Original Medicare’s coinsurance; Plan G can bring covered CGM costs near $0 after the Part B deductible. Medicare Advantage plans set their own cost-sharing, network, and authorization rules, so the Original Medicare estimate is not your plan’s quote.
Manufacturer savings cards are not valid with Medicare or Medicaid. If you have commercial coverage or pay cash, check the program’s eligibility rules and compare the final price rather than assuming a coupon is the lowest-cost route.
Stelo and Lingo are FDA-cleared OTC options sold without a prescription. They are intended for people not using insulin, have no high- or low-glucose alarms, and are not intended for diagnosis; they should not replace prescription monitoring needed for insulin treatment or low-glucose detection.
| OTC option | Listed 2026 price | Buying condition |
|---|---|---|
| Dexcom Stelo | $49.99 for a single sensor; $99 for 2 sensors covering 30 days; $89 monthly subscription | HSA/FSA eligible; sales final |
| Abbott Lingo | Around $49 for a 14-day sensor; $89 for 2; $249 for 6 | HSA/FSA eligible; first-purchase money-back policy has terms |
For occasional checks, a traditional meter may cost much less to maintain, but it does not provide the same ongoing information as a CGM. Compare ReliOn, Contour, Accu-Chek, OneTouch, and True Metrix by the matching strip cost, not just the meter’s purchase price.
Wellness subscriptions can add substantial expense. In the supplied September 2026 pricing, Signos listed $299 for a single month, while Nutrisense was around $149–$215 monthly; term commitments and included services differed.
For insulin treatment or significant lows, compare prescription devices with your clinician rather than choosing by cash price alone. Dexcom G7 and FreeStyle Libre options are worth comparing, but the exact model, covered supplies, and required accessories matter.
Evidence supporting CGM does not automatically create insurance coverage. The CONNECT trial reported a greater average A1c reduction with CGM in non-insulin-treated type 2 diabetes, and the 2026 ADA Standards recommend CGM for type 2 diabetes on non-insulin therapy; individual results vary, and coverage remains more restrictive.
Safety belongs in the comparison, too. Certain Libre 3 and Libre 3 Plus sensors were subject to a November 2025 correction involving false-low readings; Libre 2 and Libre 2 Plus were not affected. Dexcom receiver recalls in June–July 2025 involved a speaker malfunction that could silence alerts.
For an affected product, follow current manufacturer and FDA instructions and check identifying numbers rather than assuming every device from that brand is involved. Keep a backup meter available and discuss unexpected readings with your healthcare professional.
Before ordering, ask the plan and dispensing pharmacy or supplier to identify the exact device, quantity, billing route, and expected patient responsibility. Durable medical equipment, or DME, is one billing route; some plans instead process CGMs through the pharmacy benefit.
For Medicare, use a Medicare-enrolled supplier that accepts assignment, meaning it accepts the Medicare-approved amount for covered items. A cold caller’s offer of a “free monitor” is not proof of coverage, and you should not give an unsolicited caller your Medicare number.
The comparison to request is specific: What will this exact monitor and its ongoing supplies cost under my coverage, through this dispensing channel?
It may if there is a documented history of problematic hypoglycemia and the other coverage requirements are met. Without insulin treatment or that qualifying history, Medicare generally does not cover a CGM under the supplied rules.
Not automatically: Original Medicare generally requires the Part B deductible and then 20% coinsurance when the supplier accepts assignment. Supplemental coverage may reduce that share, while Medicare Advantage has plan-specific costs and rules.
No; the cited Abbott and Dexcom savings programs exclude Medicare, Medicaid, and other government programs. Commercially insured and some uninsured people may qualify under the individual program’s terms.
According to the FDA’s safety communication, no smartwatch or ring is authorized to measure glucose on its own. A watch displaying readings from a cleared CGM is different from a device claiming independent, needle-free measurement.
It may provide information to discuss with a clinician, but it is not a diagnostic test or a substitute for medical evaluation. Before paying for ongoing wear, ask what question the readings would help answer.